Literature DB >> 18729384

Structural requirements for bone sialoprotein binding and modulation of matrix metalloproteinase-2.

Alka Jain1, Abdullah Karadag, Larry W Fisher, Neal S Fedarko.   

Abstract

Bone sialoprotein (BSP) has been shown to induce limited gelatinase activity in latent matrix metalloproteinase-2 (MMP-2) without removal of the propeptide and to restore enzymatic activity to MMP-2 previously inhibited by tissue inhibitor of matrix metalloproteinase-2 (TIMP2). The current study identifies structural domains in human BSP and MMP-2 that contribute to these interactions. The 26 amino acid domain encoded by exon 4 of BSP is shown by a series of binding and activity assays to be involved in the displacement of MMP-2's propeptide from the active site and thereby inducing the protease activity. Binding assays in conjunction with enzyme activity assays demonstrate that both amino- and carboxy-terminal domains of BSP contribute to restoration of activity to TIMP2-inhibited MMP-2, while the MMP-2 hemopexin domain is not required for reactivation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18729384      PMCID: PMC2574731          DOI: 10.1021/bi801068p

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  28 in total

Review 1.  The regulation and role of osteopontin in malignant transformation and cancer.

Authors:  Mohamed K El-Tanani; Frederick Charles Campbell; Vittal Kurisetty; Dachuan Jin; Mella McCann; Philip S Rudland
Journal:  Cytokine Growth Factor Rev       Date:  2006-11-17       Impact factor: 7.638

Review 2.  Structural disorder throws new light on moonlighting.

Authors:  Peter Tompa; Csilla Szász; László Buday
Journal:  Trends Biochem Sci       Date:  2005-09       Impact factor: 13.807

Review 3.  Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.

Authors:  Rajeshwar P Verma; Corwin Hansch
Journal:  Bioorg Med Chem       Date:  2007-01-17       Impact factor: 3.641

Review 4.  The metastasis gene osteopontin: a candidate target for cancer therapy.

Authors:  G F Weber
Journal:  Biochim Biophys Acta       Date:  2001-12-28

5.  Three SIBLINGs (small integrin-binding ligand, N-linked glycoproteins) enhance factor H's cofactor activity enabling MCP-like cellular evasion of complement-mediated attack.

Authors:  Alka Jain; Abdullah Karadag; Berthold Fohr; Larry W Fisher; Neal S Fedarko
Journal:  J Biol Chem       Date:  2002-02-01       Impact factor: 5.157

6.  Factor H binding to bone sialoprotein and osteopontin enables tumor cell evasion of complement-mediated attack.

Authors:  N S Fedarko; B Fohr; P G Robey; M F Young; L W Fisher
Journal:  J Biol Chem       Date:  2000-06-02       Impact factor: 5.157

7.  SIBLING expression patterns in duct epithelia reflect the degree of metabolic activity.

Authors:  Kalu U E Ogbureke; Larry W Fisher
Journal:  J Histochem Cytochem       Date:  2007-01-08       Impact factor: 2.479

Review 8.  Small integrin-binding ligand N-linked glycoproteins (SIBLINGs): multifunctional proteins in cancer.

Authors:  Akeila Bellahcène; Vincent Castronovo; Kalu U E Ogbureke; Larry W Fisher; Neal S Fedarko
Journal:  Nat Rev Cancer       Date:  2008-03       Impact factor: 60.716

9.  Bone sialoprotein binding to matrix metalloproteinase-2 alters enzyme inhibition kinetics.

Authors:  Alka Jain; Larry W Fisher; Neal S Fedarko
Journal:  Biochemistry       Date:  2008-05-08       Impact factor: 3.162

10.  Cell type-specific post-translational modifications of mouse osteopontin are associated with different adhesive properties.

Authors:  Brian Christensen; Christian C Kazanecki; Torben E Petersen; Susan R Rittling; David T Denhardt; Esben S Sørensen
Journal:  J Biol Chem       Date:  2007-05-11       Impact factor: 5.157

View more
  6 in total

1.  Thrombin-dependent MMP-2 activity is regulated by heparan sulfate.

Authors:  Bon-Hun Koo; Jung Ho Han; Young Il Yeom; Doo-Sik Kim
Journal:  J Biol Chem       Date:  2010-11-01       Impact factor: 5.157

2.  Overlapping functions of bone sialoprotein and pyrophosphate regulators in directing cementogenesis.

Authors:  M Ao; M B Chavez; E Y Chu; K C Hemstreet; Y Yin; M C Yadav; J L Millán; L W Fisher; H A Goldberg; M J Somerman; B L Foster
Journal:  Bone       Date:  2017-09-01       Impact factor: 4.398

3.  Tissue- and cell-specific co-localization of intracellular gelatinolytic activity and matrix metalloproteinase 2.

Authors:  Ann Iren Solli; Bodil Fadnes; Jan-Olof Winberg; Lars Uhlin-Hansen; Elin Hadler-Olsen
Journal:  J Histochem Cytochem       Date:  2013-03-12       Impact factor: 2.479

Review 4.  Biomineralization of bone: a fresh view of the roles of non-collagenous proteins.

Authors:  Jeffrey Paul Gorski
Journal:  Front Biosci (Landmark Ed)       Date:  2011-06-01

5.  Review of matrix metalloproteinases' effect on the hybrid dentin bond layer stability and chlorhexidine clinical use to prevent bond failure.

Authors:  Peter C Moon; Jared Weaver; Carol N Brooks
Journal:  Open Dent J       Date:  2010-07-20

6.  Bone sialoprotein does not interact with pro-gelatinase A (MMP-2) or mediate MMP-2 activation.

Authors:  Queena Hwang; Sela Cheifetz; Christopher M Overall; Christopher A McCulloch; Jaro Sodek
Journal:  BMC Cancer       Date:  2009-04-22       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.